BRUSSELS: Syensqo said Thursday it has initiated a strategic review of its Performance & Care segment, a move aimed at sharpening the company’s focus on specialty materials and advanced technologies.
The segment, which includes the Novecare and Technology Solutions global business units, generated €2.0 billion in net sales and €358 million in underlying EBITDA in 2025. It is a global leader in surface chemistry solutions and specialty mining reagents, serving consumer care, agro, coatings and mining markets, a statement said.
“Since the start of the year, and along with the Board, we have undertaken a strategic assessment of our long-term direction and value creation priorities,” CEO Mike Radossich said in a statement.
“We are fully focused on accelerating our growth trajectory, driving more consistent execution, sharpening our capital discipline as well as improving cash flow delivery.”
Radossich said the company will evaluate a range of strategic options for the segment, with an emphasis on maximizing long-term value for shareholders. The review aligns with Syensqo’s intention to become a pure-play specialty materials and advanced technologies company with greater exposure to structurally attractive end markets, including aerospace and defense, electronics, healthcare, energy and advanced mobility.
The company has not set a defined timetable for the review and said there can be no assurance the process will result in any transaction.
Syensqo, a science company tracing its roots to scientific councils initiated by Ernest Solvay in 1911, employs more than 13,000 people in 30 countries.
